Navigation path

Pharmaceuticals - Community Register

  

List of nationally authorised medicinal products for human use

Iron containing intravenous medicinal products

Product name: Iron containing intravenous medicinal products
Also marketed in the EU under the name(s): ALVOFER, Cosmofer, DEXTRIFER-S, Diafer, ENDOREM, FAREMIO, FER ACTAVIS, FER IBD3 PHARMA CONSULTING, FER MYLAN, FER SANDOZ, FER TEVA PHARMA, Ferinject, Ferion, FERIV, FERLIXIT, FerMed, FERRINEMIA, FERRISAT, Ferrlecit, FERRO SACCARATO FME, Ferrologic, FERROVIN, Ferrum Lek, HEMAFER-S, HIERRO SACAROSA FME, HIERRO SACAROSA NORMON, Idafer, IJzerhydroxide sacharose complex, Injectafer, INTRAFER, IRON (III)-HYDROXIDE DEXTRAN COMPLEX/BIOMEDIC LABORATORIES, IRON SUCROSE PHARMABIDE, IRONATE, IRONCROSE, Iroprem, Jerndextran "Pharmacosmos", Monofar, Monofer, MONOFERRO, Monover, Nefro-Fer, NEPHROFEROL, Oxido Férrico Sacarosado Combino, Oxido Férrico Sacarosado Farmoz, Oxido Férrico Sacarosado Generis, Oxido Férrico Sacarosado Normon, Referen, REOXYL, SUCRO-FER, SUCROVEN, Uniferon, VENIRON, Venofer, Venotrix
Active substance: Not available
Indication: Not available
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/09/2013 Referral EMEA/H/A-31/1322 (2013)5970 of 13/09/2013